Microbiota Med Sp Z Oo competitive analysis

Explore patent oppositions filed by Microbiota Med Sp Z Oo against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition Date
Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive DisordersAMAZENTISDec 11, 2025
Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive DisordersAMAZENTISDec 11, 2025

Explore Microbiota Med Sp Z Oo's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Feb 12, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 15, 2025Urolithin A And A Composition Containing Same For External Use In Inflammations Of Various Etiologies1

Latest PTAB cases involving Microbiota Med Sp Z Oo

Discover the latest PTAB cases involving Microbiota Med Sp Z Oo, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Microbiota Med Sp Z Oo with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MICROBIOTA MED SP Z OO21 - -
AMAZENTIS13 - -